The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

COVID-19 vaccine protection fades within months due to a lack of long-lived plasma cells. Booster shots restore some immunity ...

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to ...

FDA's new COVID-19 vaccine policy may restrict low-risk individuals' access, pending clinical trials to prove benefits.

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

The national IHR (International Health Regulations) focal points in countries like Singapore and Hong Kong have conveyed to ...

In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well ...

The Food and Drug Administration is adjusting the standard of evidence needed for shots to be approved by the general public.

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

To understand the mechanism of the nasal vaccines, the researchers first injected mice with a traditional mRNA COVID-19 shot, ...

Yesterday the Vaccine Integrity Project (VIP), a panel of leading public health and policy experts, published a viewpoint on ...